Repligen Corporation
RGEN
$189.50+4.29%
End of day · as of Oct 6, 2026, 5:15 AM ET
Mkt cap
$7.43B
EV/Sales
10.0
P/E ratio
N/A
FY2025 Revenue
$738.26M
EPS (H1 2026)
$0.24
Gross Margin (FY2025)
52.32%
Profit Margin (FY2025)
6.62%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Latest reported RGEN revenue for 2025-12-31 was $738.3M. Net income was $48.9M. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. RGEN currently screens at market cap $7.43B.
Use this RGEN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RGEN income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Repligen Corporation (RGEN) is a medical instruments & supplies company in the Healthcare sector.
Latest cached Repligen Corporation (RGEN) revenue for Dec 31, 2025 was $738.3M. Net income was $48.9M. Statements: https://lician.com/financials/rgen
Repligen Corporation (RGEN) market capitalization is $7.43B on the latest cached snapshot.
Repligen Corporation (RGEN) cached previous close $181.70; day range $178.61 – $191.26; volume 1,421,295. Session quote: https://lician.com/quote/rgen
Repligen Corporation (RGEN) latest cached earnings event is "RGEN earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached RGEN filing is 8-K · Oct 6, 2026. Filings: https://lician.com/sec/rgen